Aetna, Humana, Kaiser Permanente and the UnitedHeath Group will provide data for more than 5 billion medical claims to the Health Care Cost Institute (HCCI) to offer new insights into healthcare costs, utilization, and intensity.
Aetna, Humana, Kaiser Permanente and the UnitedHeath Group will provide data for more than 5 billion medical claims to the Health Care Cost Institute (HCCI) to offer new insights into healthcare costs, utilization, and intensity.
According to the newly formed nonprofit’s press release, “HCCI’s mission is to promote independent research and analysis on the causes of rising U.S. health spending; to provide policy makers, consumers, and researchers with better, more transparent information on what is driving healthcare costs; and to help ensure that, over time, the nation is able to get greater value from its health spending.”
The four insurers’ claim data represents more than $1 trillion of healthcare activity from more than 5,000 hospitals and 1 million service providers from calendar year 2000 through the present. Additionally, the commercial data will be updated regularly to ensure its usefulness for research purposes. Data will be de-identified in accordance with Health Insurance Portability and Accountability Act requirements.
HCCI will provide access to the data to accredited researchers whose proposals meet the organiation’s data and scientific usage standards. Beginning in 2012, HCCI plans to publish its own scorecards and supporting analysis on aggregate trends of healthcare cost and utilization.
Go back to the Managed Healthcare Executive eNews newsletter.
FDA Site Inspections Decreased During Pandemic. Questions Continue about Drug Quality.
December 4th 2023A recent study has found that FDA inspections of drug manufacturing facilities have increased since the COVID-19 health emergency but have not yet returned to pre-pandemic numbers.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
RSV Vaccines for Adults: Gaps in Understanding
December 4th 2023Angela Branche, M.D., an infectious disease specialist at the University of Rochester School of Medicine, says the gaps are in a precise understanding of who is at risk for serious illness from respiratory syncytial virus and therefore who should get vaccinated.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen